ETR/IUI1 (ETR/IUI1)

Deutsche Börse Xetra: ETR/IUI1 · EUR

€401

+1.80 (+0.5%)· Recorded snapshot

Market cap	139.3B
Revenue (ttm)	10.2B
Net income (ttm)	2.6B
EPS (ttm)	€7.43
P/E (trailing)	54.0x
P/E (forward)	36.6x
Volume	570
Beta	1.46

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 10.2B
Net income (ttm): 2.6B
EPS (ttm): €7.43
P/E (trailing): 54.0x
P/E (forward): 36.6x
Market cap: 139.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E36.6

P25 n/aP50 n/aP75 n/a

Trailing P/E54

P25 n/aP50 n/aP75 n/a

ROE17.9

P25 n/aP50 n/aP75 n/a

ROIC24

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ETR/IUI1 indicators

Market & fundamental data

Available fields

239

Groups with data

Currency

USD

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	DE
Earnings date	2026-10-20
Employees	17,021
Employees change	1,383
Employees growth	8.84%
Enterprise value	EUR 135.8B
Exchange	Deutsche Börse Xetra
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1995
Industry	Medical Instruments & Supplies
Is primary listing	No
ISIN number	US46120E6023
Last earnings date	2026-10-20
Last refreshed	2026-10-28
Last stock split date	2021-10-05
Last stock split type	Forward
Market cap	EUR 139.3B
Next earnings date	2027-01-19
Price	EUR 400.80
Price currency	EUR
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-28
Symbol	etr/IUI1
Website	https://www.intuitive.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	62.06x
Average P/E ratio (3Y)	66.16x
Average P/E ratio (5Y)	66.24x
Earnings yield	1.85%
EV/Earnings	51.92x
EV/EBIT	41.04x
EV/EBITDA	33.39x
EV/FCF	42.67x
EV/Sales	13.01x
FCF / EV yield	2.34%
FCF yield	2.28%
Forward P/E	36.57x
Graham number	82.94692
Graham upside	-79.21%
Industry forward P/E	26.19x
Industry P/E	79.67x
Lynch fair value	EUR 88.77
Lynch upside	-77.75%
P/(FCF - SBC) ratio	57.02x
P/(OCF - SBC) ratio	48.41x
P/B ratio	9.77x
P/E ratio	53.96x
P/FCF ratio	43.78x
P/OCF ratio	38.52x
P/S ratio	13.61x
Price / tangible book value	10.34x
Price/EBITDA ratio	35.24x
Sector forward P/E	14.8x
Sector P/E	39.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	31.7%
EBITDA margin	38.61%
Effective tax rate	17.85%
FCF margin	30.48%
Gross margin	66.64%
Operating margin	31.7%
Pretax margin	31.26%
Profit margin	25.54%
Profit per employee	EUR 152,994
Profitable quarters	35
Profitable years	22
Revenue per employee	EUR 599,000
ROA	11.86%
ROA (5Y)	8.5%
ROCE	21.83%
ROE	17.93%
ROE (5Y)	14.94%
ROIC	23.97%
ROIC (5Y)	21.26%
SBC / revenue	7.21%
Tax / revenue	5.58%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	9.47%
EPS growth (Q)	-23.59%
EPS growth (QoQ)	-34.93%
EPS growth 10Y	14.92%
EPS growth 3Y	24.86%
EPS growth 5Y	12.27%
EPS growth years	3
FCF growth	58.41%
FCF growth (Q)	51.03%
FCF growth (QoQ)	17.14%
FCF growth 3Y	42.04%
FCF growth 5Y	13.81%
Gross profit growth	20.93%
Gross profit growth (Q)	23.71%
Gross profit growth 3Y	19.14%
Gross profit growth 5Y	15.26%
Net income growth	7.66%
Net income growth (Q)	-25.78%
Net income growth (QoQ)	-36.1%
Net income growth 3Y	24.93%
Net income growth 5Y	11.85%
Net income growth years	3
OCF growth	38.13%
OCF growth (Q)	45.55%
OCF growth (QoQ)	15.37%
OCF growth 10Y	14.67%
OCF growth 3Y	26.43%
OCF growth 5Y	13.73%
Operating income growth	30.34%
Operating income growth (Q)	33.58%
Operating income growth 3Y	28.81%
Operating income growth 5Y	15.49%
Revenue growth	20.45%
Revenue growth (Q)	21.7%
Revenue growth (QoQ)	5.41%
Revenue growth 10Y	16.02%
Revenue growth 3Y	19.11%
Revenue growth 5Y	16.1%
Revenue growth quarters	24
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -432.8M
Depreciation and amortization	EUR 718.4M
EBIT	EUR 3.2B
EBITDA	EUR 3.9B
EPS	EUR 7.43
Financing cash flow	EUR -4.1B
Free cash flow	EUR 3.2B
Free cash flow minus SBC	EUR 2.4B
Gross profit	EUR 6.8B
Income taxes	EUR 568.8M
Investing cash flow	EUR 658.1M
Net cash flow	EUR 152.3M
Net income	EUR 2.6B
Operating cash flow minus SBC	EUR 2.9B
Operating income	EUR 3.2B
Revenue	EUR 10.2B
Stock-based compensation	EUR 735.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	32.46
Book value per share	EUR 40.62
Debt / equity	0
Goodwill	EUR 500.7M
Long-term assets	EUR 9.5B
Long-term liabilities	EUR 571.6M
Net cash (debt)	EUR 3.6B
Net cash / market cap	2.57%
Net cash growth	-17.65%
Net debt / EBITDA	-0.9
Net debt / equity	-0.25
Net debt / FCF	-1.12
Piotroski F-Score	6
Property, plant and equipment	EUR 5.1B
Shareholders' equity	EUR 14.2B
Tangible book value	EUR 13.4B
Tangible book value per share	EUR 38.70
Total assets	EUR 17B
Total cash	EUR 3.6B
Total debt	EUR 0
Total liabilities	EUR 2.8B
WACC	12.3%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.6
Current assets	EUR 7.6B
Current liabilities	EUR 2.3B
Current ratio	3.33
Inventory turnover	1.98
Net working capital	EUR 1.6B
Quick ratio	2.32
Working capital	EUR 5.2B
Working capital turnover	1.62

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.75%
Shareholder yield	1.75%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 357.41
1D price change	0.45%
1M price change	13.69%
1M total return	13.69%
1W price change	3.68%
1W total return	3.68%
1Y price change	-14.82%
1Y return CAGR	-14.83%
1Y total return	-14.82%
20-day SMA	EUR 380.03
200-day SMA	EUR 373.67
3M price change	28.25%
3M total return	28.25%
3Y price change	62.9%
3Y return CAGR	17.66%
3Y total return	62.9%
50-day SMA	EUR 349.88
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 516.10
52-week high date	2026-01-07
52-week low	EUR 290.45
52-week low date	2026-07-23
5Y price change	34.48%
5Y return CAGR	6.1%
5Y total return	34.48%
6M price change	-0.95%
6M total return	-0.95%
All-time high	EUR 594.40
All-time high date	2025-01-23
All-time low	EUR 178.40
All-time low date	2022-06-16
Average true range (ATR)	EUR 9.20
Average volume	560.3
Beta (5Y)	1.46
Change from 52-week high	-22.34%
Change from 52-week low	37.99%
Change from all-time high	-32.44%
Change from all-time low	125.08%
Change from open	1.05%
Day's gap	-0.59%
Dollar volume	EUR 228,456
High price	EUR 403.00
Low price	EUR 394.40
Monthly RSI	51.12
Open price	EUR 396.65
Position in 52-week range	74.42%
Previous close	EUR 399.00
Price vs 150-day SMA	12.35%
Price vs 20-day SMA	5.66%
Price vs 200-day SMA	7.46%
Price vs 50-day SMA	14.77%
Relative volume	1.07
RSI	70.7
Sharpe ratio	-0.39
Sharpe ratio (3Y)	0.49
Sharpe ratio (5Y)	0.19
Sortino ratio	-0.36
Sortino ratio (3Y)	0.89
Sortino ratio (5Y)	0.44
Volume	570
Weekly RSI	60.37
YTD price change	-17.92%
YTD total return	-17.92%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	344.6M
Shares change (QoQ)	-1.6%
Shares change (YoY)	-1.75%
Shares held by insiders	0.48%
Shares held by institutions	90.11%
Short ratio	3 days

Deeper analysis on ETR/IUI1

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ETR/IUI1 report

Is a complete ETR/IUI1 research report available?

No complete published report is available for etr/IUI1 (ETR/IUI1) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ETR/IUI1 (ETR/IUI1)

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/IUI1

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/IUI1 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ETR/IUI1

Frequently asked questions